Navigation Links
Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
Date:12/14/2009

ny. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in over 20 countries including many of the world's established and growing international markets.

In the U.S., the Watson portfolio includes RAPAFLO, GELNIQUE, Oxytrol®, TRELSTAR® LA and TRELSTAR® Depot, Ferrlecit®, and INFeD®. In addition, Watson markets the following brands under co-promotion agreements: AndroGel®, with Solvay Pharmaceuticals, Inc., and Femring®, with Warner Chilcott Limited. The Watson pipeline portfolio includes a number of products, including a six-month formulation of TRELSTAR®, for the treatment of advanced prostate cancer which is currently under review by the FDA; URACYST®, under development for cystitis; and a novel new oral contraceptive.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Statements contained in this press release that refer to Watson's estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. For instance, any statements in this press release concerning prospects related to Watson's strategic initiatives, product introductions and anticipated financial performance are forward-looking statements. It is important to note that Watson's goals and expectations are not predictions of actual performance. Watson's performance, at times, will differ from its goals and expectations. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among ot
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Present at Credit Suisse Healthcare Conference
8. Watson Files FDA Application for Generic Rozerem(R)
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22 2015 /CNW/ - The Taskforce representing Canada,s ... all the hard work that the Minister and Health Canada ... This program recognizes the needs of the thalidomide survivors, and ... a year, tax free, with annual adjustments for inflation. ... annual payments of $100,000 based on the severity of their ...
(Date:5/22/2015)... -- BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading developer, ... and cryopreservation freeze media and precision ... the "Company"), announced that the Company is scheduled to present ... Company is scheduled to present at the Conference at 1:30 ... Hyatt Hotel in New York City ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015  RegeneRx ... focused on tissue protection, repair and regeneration, today announced ... RegeneRx, is scheduled to present a corporate overview at ... will present at the SeeThruEquity 4 th Annual ... New York City at 11:00 am ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3
... 2011 Masimo (NASDAQ: ... of Health & Human Services (HHS) has added Critical ... as a national newborn screening standard.  In addition, the ... detection, published online in the Lancet (appearing ...
... Janssen Biotech, Inc. announced today that the U.S. ... for the treatment of moderately to severely active ulcerative ... inadequate response to conventional therapy.  This marks the 16th ... for the anti-tumor necrosis factor (TNF)-alpha in the treatment ...
Cached Medicine Technology:U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 2U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 3U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 4U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 5U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 6U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 7U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 8U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 9U.S. Health & Human Services Makes Critical Congenital Heart Defect Screening Using Motion-Tolerant Pulse Oximetry a Nationwide Newborn Screening Standard 10REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 2REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 3REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 4REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 5REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 6REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 7REMICADE® Receives FDA Approval as First Biologic Treatment for Pediatric Ulcerative Colitis 8
(Date:5/24/2015)... (PRWEB) May 24, 2015 EnviroLeather™ ... launches “InkGard™ Plus” – a classic, rugged leather ... polymer allowing difficult stains, including ink, to be ... different colors suitable for corporate, healthcare, hospitality and ... line with EnviroLeather’s goal of developing products that ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... May 23, 2015 With the implementation ... are finding it increasingly difficult to provide their employees ... to provide adequate insurance for employees stand to face ... such an integral part of a business’s success or ... for businesses, Online USA Doctors has created a varying ...
(Date:5/23/2015)... Janesville, WI (PRWEB) May 23, 2015 ... Mercy Acceleration at the Sports Medicine and Rehabilitation Center, ... running clinic program, Mondays, June 1-July 20, 5:30-6:30 pm. ... MS, USAT coach, and Laurie Finke, RN, BSN, who ... flexibility exercises, education on nutrition, running mechanics and show ...
(Date:5/22/2015)... Francisco, CA (PRWEB) May 22, 2015 ... hosting two exciting events in June. They will hold ... Professional Doctorate and a two-day class on Classical Chinese ... p.m. June 3, Dr. Steve Given, the Dean of ... will discuss the new First Professional Doctorate program. ACTCM ...
Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2
... TORONTO, Feb. 12 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... the company,s,business direction in light of the recent decision ... to the FDA, PreMD today filed a request ... accordance with the following Code of Federal Regulations 21,CFR ...
... Asoyia-MO is the first and only soybean oil to provide ... fats per serving, and light, clean taste., IOWA CITY, ... a new product that not only meets the increasing,consumer demand ... of stability and neutral taste so important to food processors., ...
... individuals or families may have underlying speech deficits ... a personal or family history of learning disabilities may ... dementia that causes them to lose language abilities as ... The condition, known as primary progressive aphasia, causes language ...
... Comprehensive Account of Global Trends, Progress and ... with Response Planning, ANNAPOLIS, Md., Feb. 12 ... global intelligence and business resiliency services,today announced the ... and,Pandemic Planning. Created by iJET,s health intelligence team, ...
... and American Heart Association Join Forces to,Educate, ... Health, CHICAGO, Feb. 12 A recent ... Heart,Association found that, among African-Americans, two out of ... and two out of,five (40 percent) expressed concern ...
... Hutchinson - Named President and CEO of Prematics(TM) - ... Advancing Physician Adoption of Electronic Prescribing, BETHESDA, ... named Kevin Hutchinson, one of the nation,s most respected ... chief,executive officer of SureScripts, to lead the company,s next ...
Cached Medicine News:Health News:PreMD Initiates FDA Review Process and Provides Corporate Update 2Health News:PreMD Initiates FDA Review Process and Provides Corporate Update 3Health News:Asoyia Announces New Mid Oleic Ultra Low Lin Soybean Oil 2Health News:Learning Disabilities May Presage Later Language Problems 2Health News:iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning 2Health News:iJET Unveils 2007 Year-in-Review Report on Avian Influenza and Pandemic Planning 3Health News:New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 2Health News:New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 3Health News:New Survey Shows African-Americans Are Concerned With Heart Health but Unaware of Link to Brain Health 4Health News:Founding CEOS of SureScripts(R) and RxHub(R) Join Forces to Deliver Clinical Information Technology Services to Physician Practices 2Health News:Founding CEOS of SureScripts(R) and RxHub(R) Join Forces to Deliver Clinical Information Technology Services to Physician Practices 3
... Profile Ergonomic Design for Neurosurgery. ... offers rigid working channel scopes ... The rigid scope body facilitates ... the target. The steerable tip ...
... Ethisorb Dura Patch is a synthetic absorbable ... and. spinalis defects. Ethisorb Dura Patch is pliable, ... cut to the desired shape, care must be ... violet dyed, PDS foil covered side is oriented ...
... patch, Duragen is a matrix for ... handles and conforms similar to normal ... matrix for dural closure. Remarkable onlay ... defects. Fully resorbed following complete tissue ...
Elmed electrosurgical systems for major surgery....
Medicine Products: